Investigation of in vitro genotoxic effects of an anti-diabetic drug sitagliptin
Keywords: Sitagliptin; Antidiabetic drug; Human lymphocytes; Genotoxicity; T2DM; Type 2 diabetes mellitus; DPP-4; dipeptidyl peptidase-4; GLP-1; incretin hormones glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypeptide; CAs; chromosome aberration